Eli Lilly Covid Antibody Drug Gets Emergency FDA Clearance - THEMARKETTRENDZ

Post Top Ad

Monday, 9 November 2020

Eli Lilly Covid Antibody Drug Gets Emergency FDA Clearance



Nov.09 -- Pfizer Inc. and BioNTech SE are reporting positive results from their covid-19 vaccine trials, signaling a major breakthrough in the fight to contain the worst outbreak in a century. Meanwhile, Eli Lilly & Co.'s covid-19 antibody therapy has just been granted emergency FDA clearance. Bloomberg’s Michelle Cortez reports on “Bloomberg Daybreak: Asia.”
View on YouTube

No comments:

Post a comment

Post Bottom Ad